International Flavors & Fragrances Inc (IFF)

NYSE
Currency in USD
78.01
-1.33(-1.68%)
Real-time Data
IFF Scorecard
Full Analysis
High shareholder yield
Trading near 52-week Low
Fair Value
Day's Range
77.2979.63
52 wk Range
77.29106.77
Key Statistics
Edit
Prev. Close
79.74
Open
78.75
Day's Range
77.29-79.63
52 wk Range
77.29-106.77
Volume
577.65K
Average Volume (3m)
1.57M
1-Year Change
-4.98%
Book Value / Share
54.27
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IFF Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
99.62
Upside
+27.71%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

International Flavors & Fragrances Inc Company Profile

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, pharma solutions, and complementary adjacent products in the United States, Europe, and internationally. It operates in four segments Nourish, Health & Biosciences, Scent, and Pharma Solutions. The Nourish segment consists of portfolio of natural-based ingredients that includes plant-based specialty food ingredients, such as soy and pea protein with value-added formulations, emulsifiers, and sweeteners; food protection ingredients, including natural antioxidants, and anti-microbials for natural food preservation and shelf-life extension; savory solutions, such as spices, marinades, and mixtures; combining flavourings with fruits, vegetables, and other natural ingredients products; a range of flavor compounds used in savory products, such as soups, sauces, meat, fish, poultry, and snacks; and beverages juice drinks, carbonated or flavored beverages, and spirits, as well as sweets bakery products, candy, cereal, and chewing gum; and dairy products, such as yogurt, ice cream, and cheese, as well as spices and seasoning ingredients. Its Health & Biosciences is comprised of health, cultures and food enzymes, home and personal care, animal nutrition, and grain processing. The Scent segment creates fragrance compounds, and fragrance ingredients. Its Pharma Solutions segment produces cellulosics and seaweed-based pharmaceutical excipients. The company was incorporated in 1909 and is headquartered in New York, New York.

Employees
22400

International Flavors & Fragrances Inc SWOT Analysis


Financial Resilience
IFF's strong Q3 2024 results align with industry trends, showcasing operational efficiency amid challenging economic conditions
Market Dynamics
Explore IFF's position in a transitioning flavors and fragrances sector, balancing cautious optimism with anticipated growth normalization
Strategic Outlook
Delve into IFF's potential for upward guidance revision and its ability to navigate weaker volume trends in end-markets
Analyst Perspectives
Barclays sets price targets ranging from $90 to $99, reflecting varied views on IFF's growth prospects and market challenges
Read full SWOT analysis

International Flavors & Fragrances Inc Earnings Call Summary for Q3/2024

  • IFF raises full-year guidance: Net sales $11.3-11.4B, adjusted EBITDA at high end of $2.1-2.17B range
  • Q3 revenue surpassed $2.9B, up 9% on comparable currency-neutral basis; high-single-digit volume growth across units
  • Pharma Solutions divestiture planned for H1 2025; organizational changes for Flavors and Functional Ingredients separation in 2024
  • Cautious Q4 outlook due to potential customer inventory adjustments; free cash flow guidance remains at ~$600M
  • Focus on innovation and productivity for 2025; strong growth in Nourish, Health & Biosciences, and Pharma Solutions segments
Last Updated: 07/11/2024, 08:54
Read Full Transcript

Compare IFF to Peers and Sector

Metrics to compare
IFF
Peers
Sector
Relationship
P/E Ratio
82.0x22.7x0.0x
PEG Ratio
0.770.170.00
Price/Book
1.4x1.6x1.6x
Price / LTM Sales
1.7x1.5x1.2x
Upside (Analyst Target)
26.7%0.0%27.0%
Fair Value Upside
Unlock14.6%2.8%Unlock

Analyst Ratings

16 Buy
5 Hold
1 Sell
Ratings:
22 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 99.62
(+27.71% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.95%
Dividend Yield
1.99%
Industry Median 3.45%
Annualised payout
1.60
Paid quarterly
5-Years Growth
-11.58%
Growth Streak

Earnings

Latest Release
Feb 18, 2025
EPS / Forecast
0.97 / 0.82
Revenue / Forecast
2.80B / 2.69B
EPS Revisions
Last 90 days

People Also Watch

479.25
LMT
+2.68%
129.11
VST
-2.12%
189.26
AVGO
-0.67%
93.71
MRK
-1.08%
210.46
ABBV
-0.71%

FAQ

What Is the IFF (IFF) Premarket Price Today?

The IFF (IFF) premarket price is . Premarket price change units: . Premarket percentage change: . Premarket volume: . Current date: 21 Mar 2025. Previous close: 79.74

What Stock Exchange Does IFF Trade On?

IFF is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for IFF?

The stock symbol for IFF is "IFF."

What Is the IFF (IFF) Afterhours Price Today? (Afterhours variable test: ) Current Date: 21 Mar 2025

After hours price: . After hours price change (units): . Price change percentage:

What Is the IFF Market Cap?

As of today, IFF market cap is 19.87B.

What is IFF Earnings Per Share?

The IFF EPS is 0.949.

What Is the Next IFF Earnings Date?

IFF will release its next earnings report on 11 May 2025.

From a Technical Analysis Perspective, Is IFF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.